Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Quest Diagnostics
(NY:
DGX
)
138.42
+0.26 (+0.19%)
Official Closing Price
Updated: 7:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Quest Diagnostics
< Previous
1
2
3
4
5
6
7
Next >
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
February 03, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Recap: Quest Diagnostics Q4 Earnings
February 03, 2022
Quest Diagnostics (NYSE:DGX) reported its Q4 earnings results on Thursday, February 3, 2022 at 06:45 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Scheduled For February 3, 2022
February 03, 2022
Companies Reporting Before The Bell • Tuesday Morning (NASDAQ:TUEM) is likely to report earnings for its second quarter.
Via
Benzinga
7 Undervalued Stocks That Won’t Stay That Way for Long
January 25, 2022
With growing concerns about stability inducing significant fear, contrarians may have an opportunity with undervalued stocks.
Via
InvestorPlace
FeganScott Announces Investigation into Prenatal Testing Options Revealing Flawed Genetic Results
January 17, 2022
--News Direct--
Via
News Direct
Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022
February 02, 2022
Upgrades Oppenheimer upgraded the previous rating for NovoCure Ltd (NASDAQ:NVCR) from Perform to Outperform. NovoCure earned $0.13 in the third quarter, compared to $0.09...
Via
Benzinga
26 Firms Going Ex-Dividend Next Week, Including CVS Health, APA Corp. And Procter & Gamble
January 14, 2022
There are several well known large cap stocks going ex-dividend next week including 4 of our Top 100 Dividend Stocks.
Via
Talk Markets
Monday Is Your Last Chance To Buy Quest Diagnostics Before The Dividend Payout
January 13, 2022
Monday marks the last chance for investors to receive the next dividend payout from Quest Diagnostics. What's Happening (NYSE:
Via
Benzinga
Quest Diagnostics Inc Slammed After Earnings, Here’s Where It's Going
January 12, 2022
The next major support level for Quest Diagnostics Inc stock will be around the $140.00 level. This support area is where the stock broke out to the upside in early November 2021.
Via
Talk Markets
Quest Diagnostics Stock Falls As FY22 EPS Outlook Lags Consensus
January 12, 2022
Quest Diagnostics Inc (NYSE: DGX) expects Q4 sales of $2.74 billion, a decrease of 9% Y/Y, beating the consensus of $2.54 billion. The company noted preliminary Q4...
Via
Benzinga
Free COVID Tests: What Stocks Will Benefit?
December 23, 2021
The government hasn’t announced yet what company or companies it will be buying from, but there are several businesses involved in producing these kits.
Via
Talk Markets
QDEL Stock Alert: What Is Going on With Quidel Today?
December 20, 2021
The nearing holidays mean an increasing demand for Covid-19 testing kits. Leading provider Quidel is seeing QDEL stock rise as a result.
Via
InvestorPlace
Price Over Earnings Overview: Quest Diagnostics
December 14, 2021
In the current session, Quest Diagnostics Inc. (NYSE:DGX) is trading at $163.60, after a 0.21% gain. Over the past month, the stock increased by 10.55%, and in the past...
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
November 29, 2021
What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
7 Stocks to Buy as America Lifts Its Travel Ban
November 19, 2021
With the Biden administration making the move to open U.S. land borders with Canada and Mexico, these stocks to buy can get a boost.
Via
InvestorPlace
Exposures
COVID-19
Why This Diagnostics Stock Is a Buy
November 18, 2021
Quest Diagnostics beat analysts' estimates in the third quarter and raised its guidance for this year again.
Via
The Motley Fool
Wall Street Crime And Punishment: The Blood On Elizabeth Holmes' Fingers
November 12, 2021
Does crime pay? Wall Street Crime and Punishment is a weekly series by Benzinga's Phil Hall chronicling the bankers, brokers and financial ne’er-do-wells whose ambition...
Via
Benzinga
What 5 Analyst Ratings Have To Say About Quest Diagnostics
October 26, 2021
Within the last quarter, Quest Diagnostics (NYSE:DGX) has observed the follow...
Via
Benzinga
Quest Diagnostics Inc (DGX) Q3 2021 Earnings Call Transcript
October 21, 2021
DGX earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Quest Diagnostics: Q3 Earnings Insights
October 21, 2021
Quest Diagnostics (NYSE:DGX) reported its Q3 earnings results on Thursday, October 21, 2021 at 06:45 AM. Here's what investors need to know about the announcement....
Via
Benzinga
Quest Raises FY21 Outlook Again On Strong COVID-19 Volumes In Q3
October 21, 2021
Quest Diagnostics Incorporated (NYSE: DGX) has posted a better-than-expected Q3 adjusted EPS of $3.96, down 7.9% Y/Y, beating the consensus estimate of $2.87. Sales...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO
October 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus CDC Committee Recommends Approval Of Merck, Pfizer's Pneumococcal Vaccine...
Via
Benzinga
Exposures
Product Safety
Earnings Scheduled For October 21, 2021
October 21, 2021
Companies Reporting Before The Bell • Tri Pointe Homes (NYSE:TPH) is estimated to report quarterly earnings at $0.89 per share on revenue of $946.97 million. •...
Via
Benzinga
Earnings Outlook For Quest Diagnostics
October 20, 2021
Quest Diagnostics (NYSE:DGX) is set to give its latest quarterly earnings report on Thursday, 2021-10-21. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
Price Over Earnings Overview: Quest Diagnostics
October 19, 2021
Right now, Quest Diagnostics Inc. (NYSE:DGX) share price is at $145.77, after a 1.43% gain. Moreover, over the past month, the stock fell by 5.60%, but in the past...
Via
Benzinga
The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
October 18, 2021
Biotech stocks rebounded in the week ended Oct. 15, bouncing from third straight weekly losses. The strength came amid a broader market rally and some sector-specific news....
Via
Benzinga
Exposures
Product Safety
Overview Of Value Stocks In The Healthcare Sector
October 04, 2021
What is a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
The Delta Variant Has Made Quest Diagnostics Indispensable
September 29, 2021
On the back of steady demand for COVID-19 testing, Quest Diagnostics bumped up its guidance for this year.
Via
The Motley Fool
Exposures
COVID-19
Instead of Buying Dogecoin, Invest in These 3 Companies That Are Bullish on Blockchain Technology
September 16, 2021
These businesses have exposure to blockchain technology and they're safer options than buying crypto directly.
Via
The Motley Fool
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
September 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.